First Time Loading...

ImmuCell Corp
NASDAQ:ICCC

Watchlist Manager
ImmuCell Corp Logo
ImmuCell Corp
NASDAQ:ICCC
Watchlist
Price: 5.3 USD 0.19% Market Closed
Updated: Mar 29, 2024

Intrinsic Value

ICCC's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. [ Read More ]

The intrinsic value of one ICCC stock under the Base Case scenario is 7.87 USD. Compared to the current market price of 5.3 USD, ImmuCell Corp is Undervalued by 33%.

Key Points:
ICCC Intrinsic Value
Base Case
7.87 USD
Undervaluation 33%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
ImmuCell Corp

Backtest ICCC Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ICCC stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of ImmuCell Corp's business.

What risks and challenges
does ImmuCell Corp face in the near future?

Summarize the latest earnings report
of ImmuCell Corp.

Provide P/E
for ImmuCell Corp and its competitors.

Financials

Balance Sheet Decomposition
ImmuCell Corp

Current Assets 12m
Cash & Short-Term Investments 2m
Receivables 2m
Other Current Assets 8m
Non-Current Assets 32.6m
PP&E 32.4m
Intangibles 140k
Other Non-Current Assets 80k
Current Liabilities 3.3m
Accounts Payable 780k
Accrued Liabilities 930k
Other Current Liabilities 1.6m
Non-Current Liabilities 15.2m
Long-Term Debt 10.9m
Other Non-Current Liabilities 4.3m
Efficiency

Earnings Waterfall
ImmuCell Corp

Revenue
17.5m USD
Cost of Revenue
-13.6m USD
Gross Profit
3.9m USD
Operating Expenses
-9.6m USD
Operating Income
-5.7m USD
Other Expenses
-27k USD
Net Income
-5.8m USD

Free Cash Flow Analysis
ImmuCell Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

ICCC Profitability Score
Profitability Due Diligence

ImmuCell Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Negative 1-Year Revenue Growth
Declining ROIC
26/100
Profitability
Score

ImmuCell Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

ICCC Solvency Score
Solvency Due Diligence

ImmuCell Corp's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Positive Net Debt
42/100
Solvency
Score

ImmuCell Corp's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ICCC Price Targets Summary
ImmuCell Corp

Wall Street analysts forecast ICCC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ICCC is 14 USD .

Lowest
Price Target
Not Available
Average
Price Target
14 USD
164% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

ICCC Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

ICCC Price
ImmuCell Corp

1M 1M
+0%
6M 6M
-1%
1Y 1Y
+4%
3Y 3Y
-43%
5Y 5Y
-17%
10Y 10Y
+10%
Annual Price Range
5.3
52w Low
4.45
52w High
5.98
Price Metrics
Average Annual Return 3.35%
Standard Deviation of Annual Returns 28%
Max Drawdown -63%
Shares Statistics
Market Capitalization 41.1m USD
Shares Outstanding 7 750 860
Percentage of Shares Shorted 0.1%

ICCC Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

ImmuCell Corp Logo
ImmuCell Corp

Country

United States of America

Industry

Biotechnology

Market Cap

41.1m USD

Dividend Yield

0%

Description

ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company is headquartered in Portland, Maine and currently employs 60 full-time employees. The firm is engaged in development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. The company manufactures and markets the First Defense product line for the prevention of scours in newborn dairy and beef calves. The company expanded this line into five different products with formulations targeting E. coli and coronavirus pathogens, as well as E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. These product line provides Immediate Immunity to newborn calves. The firm is engaged in development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. Its products reduce the use of traditional antibiotics in food producing animals.

Contact

MAINE
Portland
56 Evergreen Dr
+12078782770.0
http://www.immucell.com/

IPO

1987-05-01

Employees

60

Officers

President, CEO, Principal Financial Officer, Treasurer, Secretary & Director
Mr. Michael F. Brigham
VP of Sales & Marketing and Director
Ms. Bobbi Jo Brockmann
Director of Finance & Administration
Elizabeth S. Toothaker
Senior Director of Quality
Mr. A. Gustavo Scaffa
Director of Product Development
John W. Zinckgraf

See Also

Discover More
What is the Intrinsic Value of one ICCC stock?

The intrinsic value of one ICCC stock under the Base Case scenario is 7.87 USD.

Is ICCC stock undervalued or overvalued?

Compared to the current market price of 5.3 USD, ImmuCell Corp is Undervalued by 33%.